Study on preparation, characterization and multidrug resistance reversal of red blood cell membrane-camouflaged tetrandrine-loaded PLGA nanoparticles

References

• Caitriona H. (2013). Cancer drug resistance: an evolving paradigm, Nature reviews. Cancer 13:714–26.
   PubMed Web of Science ®Google Scholar
• Cang J, Guo K. (2016). A novel tetrandrine-loaded chitosan microsphere: characterization and in vivo evaluation. Drug Design Dev Ther 10:1291–8.
   PubMed Web of Science ®Google Scholar
• Cao X, Luo J, Gong T, et al. (2015). Co-encapsulated doxorubicin and bromotetrandrine lipid nanoemulsions in reversing multidrug resistance in breast cancer in vitro and in vivo. Mol Pharm 12:274–86.
   PubMed Web of Science ®Google Scholar
• Chen H-y, Chen X-y. (2013). Tetrandrine reversed the resistance of tamoxifen in human breast cancer MCF-7/TAM cells: an experimental research. Zhongguo Zhong Xi Yi Jie He Za Zhi 33:488–91.
   PubMedGoogle Scholar
• Cheng J, Cheng L, Chen B, et al. (2012). Effect of magnetic nanoparticles of Fe3O4 and wogonin on the reversal of multidrug resistance in K562/A02 cell line. Int J Nanomed 7:2843–52.
   PubMed Web of Science ®Google Scholar
• Chen J, Wang W, Wang H, et al. (2014). Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis. Drug Discov Ther 8:33–41.
   PubMedGoogle Scholar
• Fan C, Li X, Zhou Y, et al. (2013). Enhanced topical delivery of tetrandrine by ethosomes for treatment of arthritis. BioMed Res Int 2013:161943.
   PubMed Web of Science ®Google Scholar
• Gao W, Hu C-M, H Fang R, et al. (2013). Surface functionalization of gold nanoparticles with red blood cell membranes. Adv Mater Weinheim 25:3549–53.
   PubMed Web of Science ®Google Scholar
• Guo L, Zhang H, Wang F, et al. (2015). Targeted multidrug-resistance reversal in tumor based on PEG-PLL-PLGA polymer nano drug delivery system. Int J Nanomed 10:4535–47.
   PubMed Web of Science ®Google Scholar
• Hochmuth RM, Evans CA, Wiles HC, et al. (1983). Mechanical measurement of red cell membrane thickness. Science 220:101–2.
   PubMed Web of Science ®Google Scholar
• Hongbo Fang R, Hu C-M, Zhang L. (2012). Nanoparticles disguised as red blood cells to evade the immune system. Exper Opin Biol Ther 12:385–9.
   PubMed Web of Science ®Google Scholar
• Jia L, Li Z, Shen J, et al. (2015). Multifunctional mesoporous silica nanoparticles mediated co-delivery of paclitaxel and tetrandrine for overcoming multidrug resistance. Int J Pharm 489:318–30.
   PubMed Web of Science ®Google Scholar
• Jiawei L. (2014). Preparation and evaluation of charged solid lipid nanoparticles of tetrandrine for ocular drug delivery system: pharmacokinetics, cytotoxicity and cellular uptake studies. Drug Dev Ind Pharm 40:980–7.
   PubMed Web of Science ®Google Scholar
• K Makadia H, Siegel S. (2011). Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers 3:1377–97.
   PubMed Web of Science ®Google Scholar
• Khan I, Gothwal A, Sharma A, et al. (2016). PLGA nanoparticles and their versatile role in anticancer drug delivery. Crit Rev Ther Drug Carrier Syst 33:159–93.
   PubMed Web of Science ®Google Scholar
• Li X, Lu X, Xu H, et al. (2012). Paclitaxel/tetrandrine coloaded nanoparticles effectively promote the apoptosis of gastric cancer cells based on “oxidation therapy”. Mol Pharm 9:222–9.
   PubMed Web of Science ®Google Scholar
• Lien J-C, Lin M-W, Chang S-J, et al. (2017). Tetrandrine induces programmed cell death in human oral cancer CAL 27 cells through the reactive oxygen species production and caspase-dependent pathways and associated with beclin-1-induced cell autophagy. Environ Toxicol 32:329–43.
   PubMed Web of Science ®Google Scholar
• Liu W, Kou B, Ma Z-K, et al. (2015). Tetrandrine suppresses proliferation, induces apoptosis, and inhibits migration and invasion in human prostate cancer cells. Asian J Androl 17:850–3.
   PubMed Web of Science ®Google Scholar
• Liu T, Liu X, Li W. (2016). Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy. Oncotarget 7:40800–15.
   PubMedGoogle Scholar
• Lu M, Fei Z, Zhang G. (2017). Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN/Akt signaling pathway. Biomed Pharmacother 97:1282–8.
   PubMed Web of Science ®Google Scholar
• Lu Y, Li F, Xu T, Sun J. (2017). Tetrandrine prevents multidrug resistance in the osteosarcoma cell line, U-2OS, by preventing Pgp overexpression through the inhibition of NF-κB signaling. Int J Mol Med 39:993–1000.
   PubMed Web of Science ®Google Scholar
• Mayur Y, Jagadeesh S, N Thimmaiah K. (2007). Targeting calmodulin in reversing multi drug resistance in cancer cells. Mrmc 6:1383–9.
   Web of Science ®Google Scholar
• Oldenborg P-A, Zheleznyak A, Fang YY-F, et al. (2000). Role of CD47 as a Marker of Self on Red Blood Cells. Science 288:2051–4.
   PubMed Web of Science ®Google Scholar
• Ren Y, Zhang H, Chen B, et al. (2012). Multifunctional magnetic Fe3O4 nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance. Int J Nanomed 7:2261–9.
   PubMed Web of Science ®Google Scholar
• Shi C, Meng R, Li K. (2016). Preparation and in vitro evaluation of tetrandrine-loaded composite microspheres embedded with PLGA nanoparticles. Chin J Chin Materia Medica 41:838–44.
   Google Scholar
• Si M, Zhao J, Li X, et al. (2013). Reversion effects of curcumin on multidrug resistance of MNNG/HOS human osteosarcoma cells in vitro and in vivo through regulation of P-glycoprotein. Chin Med J 126:4116–23.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. (2018). Cancer statistics, 2018. CA 68:7–30.
   Google Scholar
• Singh K, Dong Q, S TimiriShanmugam P, et al. (2018). Tetrandrine inhibits deregulated cell cycle in pancreatic cancer cells: differential regulation of p21 Cip1/Waf1, p27 Kip1 and cyclin D1. Cancer Lett 425:164–73.
   PubMed Web of Science ®Google Scholar
• Slichenmyer WJ, Hoff DD. (1990). New natural products in cancer chemotherapy. J Clin Pharm 30:770–88.
   PubMed Web of Science ®Google Scholar
• Sun Y, Su J, Liu G, et al. (2017). Advances of blood cell-based drug delivery systems. Eur J Pharm Sci 96:115–28.
   PubMed Web of Science ®Google Scholar
• T Palayoor S, M Stein J, N Hait W. (1987). Inhibition of protein kinase C by antineoplastic agents: implications for drug resistance. Biochem Biophys Res Commun 148:718–25.
   PubMed Web of Science ®Google Scholar
• Tan S, Wu T, Zhang D, Zhang Z. (2015). Cell or cell membrane-based drug delivery systems. Theranostics 5:863–81.
   PubMed Web of Science ®Google Scholar
• Tsuruo T, Kawabata H, Nagumo N, et al. (1985). Potentiation of antitumor agents by calcium channel blockers with special reference to cross-resistance patterns. Cancer Chemother Pharm 15:16–9.
   PubMed Web of Science ®Google Scholar
• Wang K, Ma L, Bu G. (2017). Tetrandrine reverses the drug resistance of colon cancer to 5-fluorouracil. Biomed Res 28:4843–8.
   Google Scholar
• Wen X, Zhang H-D, Zhao L, et al. (2015). Ginsenoside Rh2 differentially mediates microRNA expression to prevent chemoresistance of breast cancer. Asian Pac J Cancer Preven 16:1105–9.
   PubMedGoogle Scholar
• Ye L-Y, Hu S, Xu H-E, et al. (2017). The effect of tetrandrine combined with cisplatin on proliferation and apoptosis of A549/DDP cells and A549 cells. Cancer Cell Int 17:40.
   PubMed Web of Science ®Google Scholar
• Ye M-X, Zhao Y-L, Li Y, et al. (2012). Curcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549/DDP cell apoptosis through HIF-1α and caspase-3 mechanisms. Phytomedicine 19:779–87.
   PubMed Web of Science ®Google Scholar
• Yu WV, Shing Ho W. (2013). Tetrandrine inhibits hepatocellular carcinoma cell growth through the caspase pathway and G(2)/M phase. Oncol Rep 29:2205–10.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu X, Zuo T, et al. (2012). Tetramethylpyrazine reverses multidrug resistance in breast cancer cells through regulating the expression and function of P-glycoprotein. Med Oncol 29:534–8.
   PubMed Web of Science ®Google Scholar